These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29802225)

  • 21. Identifying patients with NTRK fusion cancer.
    Solomon JP; Benayed R; Hechtman JF; Ladanyi M
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of a novel
    Milione M; Ardini E; Christiansen J; Valtorta E; Veronese S; Bosotti R; Pellegrinelli A; Testi A; Pietrantonio F; Fucà G; Wei G; Murphy D; Siena S; Isacchi A; De Braud F
    Oncotarget; 2017 Aug; 8(33):55353-55360. PubMed ID: 28903424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biphenotypic Immunohistochemical Features and NTRK1 Amplification in Intermediate Cell Carcinoma of the Liver.
    Radhakrishnan S; Martin CA; Vij M; Raju LP; Gowripriya G; Jana K; Rammohan A; Jothimani D; Kaliamoorthy I; Veldore VH; Rela M
    Int J Surg Pathol; 2023 Aug; 31(5):839-845. PubMed ID: 36476133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
    Greco A; Miranda C; Pierotti MA
    Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
    Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
    Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
    Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
    Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low frequency of rearrangement of TRK protooncogene in Chinese thyroid tumors.
    Kuo CS; Lin CY; Hsu CW; Lee CH; Lin HD
    Endocrine; 2000 Dec; 13(3):341-4. PubMed ID: 11216646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
    Laetsch TW; DuBois SG; Mascarenhas L; Turpin B; Federman N; Albert CM; Nagasubramanian R; Davis JL; Rudzinski E; Feraco AM; Tuch BB; Ebata KT; Reynolds M; Smith S; Cruickshank S; Cox MC; Pappo AS; Hawkins DS
    Lancet Oncol; 2018 May; 19(5):705-714. PubMed ID: 29606586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer.
    Zhu ZW; Friess H; Wang L; Di Mola FF; Zimmermann A; Büchler MW
    Anticancer Res; 2000; 20(1A):125-32. PubMed ID: 10769644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of neurotrophic tyrosine kinase receptors 1 and 2 in lung carcinoma: potential discriminators between squamous and nonsquamous subtypes.
    Terry J; De Luca A; Leung S; Peacock G; Wang Y; Elliot WM; Huntsman D
    Arch Pathol Lab Med; 2011 Apr; 135(4):433-9. PubMed ID: 21466358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of NTRK1 Promotes Differentiation of Neural Stem Cells into Cholinergic Neurons.
    Wang L; He F; Zhong Z; Lv R; Xiao S; Liu Z
    Biomed Res Int; 2015; 2015():857202. PubMed ID: 26509167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital insensitivity to pain with anhidrosis (CIPA): novel mutations of the TRKA (NTRK1) gene, a putative uniparental disomy, and a linkage of the mutant TRKA and PKLR genes in a family with CIPA and pyruvate kinase deficiency.
    Indo Y; Mardy S; Miura Y; Moosa A; Ismail EA; Toscano E; Andria G; Pavone V; Brown DL; Brooks A; Endo F; Matsuda I
    Hum Mutat; 2001 Oct; 18(4):308-18. PubMed ID: 11668614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
    Drilon A; Siena S; Ou SI; Patel M; Ahn MJ; Lee J; Bauer TM; Farago AF; Wheler JJ; Liu SV; Doebele R; Giannetta L; Cerea G; Marrapese G; Schirru M; Amatu A; Bencardino K; Palmeri L; Sartore-Bianchi A; Vanzulli A; Cresta S; Damian S; Duca M; Ardini E; Li G; Christiansen J; Kowalski K; Johnson AD; Patel R; Luo D; Chow-Maneval E; Hornby Z; Multani PS; Shaw AT; De Braud FG
    Cancer Discov; 2017 Apr; 7(4):400-409. PubMed ID: 28183697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotrophin Receptors TrkA, p75
    Faulkner S; Jobling P; Rowe CW; Rodrigues Oliveira SM; Roselli S; Thorne RF; Oldmeadow C; Attia J; Jiang CC; Zhang XD; Walker MM; Hondermarck H
    Am J Pathol; 2018 Jan; 188(1):229-241. PubMed ID: 29037860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
    Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti MA
    Clin Cancer Res; 1998 Jan; 4(1):223-8. PubMed ID: 9516975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STRN3-NTRK1: A Novel NTRK1 Oncogenic Fusion in a Patient with Lung Adenocarcinoma.
    Lu R; Qi C; Xiao M; Cai S; Zheng M
    J Thorac Oncol; 2020 Feb; 15(2):e23-e24. PubMed ID: 32127185
    [No Abstract]   [Full Text] [Related]  

  • 39. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.
    Frattini M; Ferrario C; Bressan P; Balestra D; De Cecco L; Mondellini P; Bongarzone I; Collini P; Gariboldi M; Pilotti S; Pierotti MA; Greco A
    Oncogene; 2004 Sep; 23(44):7436-40. PubMed ID: 15273715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ; Koh YW; Yoon SO
    Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.